Other

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: > Other: > Other > Other: > Medicaments primarily affecting the central nervous system: > Other: > Other

Duty Rate (from China)

0%
MFN Base RateFree

Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Total Effective Rate0%

Products classified under HTS 3004.90.92.49

Sertraline 50mg Tablets

Sertraline hydrochloride tablets, 50mg per dose, used for treating depression, anxiety, and obsessive-compulsive disorder by primarily affecting serotonin levels in the central nervous system. Classified under HTS 3004.90.92.49 as a mixed/unmixed medicament in measured doses for retail sale, targeting CNS therapeutic uses. Excludes immunological products or goods in headings 3002, 3005, or 3006.

Venlafaxine ER 75mg Capsules

Extended-release venlafaxine hydrochloride capsules, 75mg, for major depressive disorder and generalized anxiety by modulating serotonin and norepinephrine in the CNS. Fits HTS 3004.90.92.49 for other CNS-affecting medicaments in retail-ready measured doses. Not covered by exclusions like foods or diagnostic reagents.

Escitalopram 10mg Tablets

Escitalopram oxalate tablets, 10mg measured dose, an SSRI antidepressant primarily targeting CNS serotonin reuptake for major depression and anxiety prophylaxis. Under HTS 3004.90.92.49 as other CNS medicaments in forms for retail sale, excluding mixtures treated as unmixed per chapter notes.

Bupropion HCl SR 150mg Tablets

Sustained-release bupropion hydrochloride 150mg tablets for smoking cessation and depression via CNS norepinephrine/dopamine reuptake inhibition. HTS 3004.90.92.49 applies to these other CNS therapeutic medicaments in measured retail doses, distinct from nicotine cessation products in 2404.

Duloxetine 30mg Delayed-Release Capsules

Duloxetine hydrochloride delayed-release 30mg capsules (Cymbalta generic) for depression, anxiety, and neuropathic pain via CNS serotonin/norepinephrine modulation. HTS 3004.90.92.49 for other CNS medicaments in retail measured forms, treated as mixed per notes if suspended.

Buspirone HCl 10mg Tablets

Buspirone hydrochloride 10mg tablets for generalized anxiety disorder by acting on CNS serotonin 5-HT1A receptors. Falls under HTS 3004.90.92.49 as other CNS-affecting therapeutic medicaments in measured retail doses.

Mirtazapine 15mg Tablets

Mirtazapine 15mg orally disintegrating tablets for major depressive disorder via CNS noradrenergic/serotonergic enhancement. HTS 3004.90.92.49 for other CNS medicaments put up for retail sale.

Lamotrigine 100mg Tablets

Lamotrigine 100mg chewable tablets for epilepsy and bipolar via CNS sodium channel stabilization. Classified HTS 3004.90.92.49 other CNS therapeutic in doses.

Atomoxetine 40mg Capsules

Atomoxetine HCl 40mg capsules for ADHD via CNS norepinephrine reuptake inhibition. HTS 3004.90.92.49 other CNS medicaments.

Memantine HCl 10mg Tablets

Memantine 10mg ER tablets for Alzheimer's via CNS NMDA antagonism. HTS 3004.90.92.49.

Quetiapine Fumarate 25mg Tablets

Quetiapine 25mg immediate-release for schizophrenia via CNS dopamine/serotonin block. HTS 3004.90.92.49.

Aripiprazole 5mg Tablets

Aripiprazole 5mg ODT for bipolar via partial CNS agonist. HTS 3004.90.92.49.

Ramelteon 8mg Tablets

Ramelteon 8mg for insomnia via CNS melatonin agonism. HTS 3004.90.92.49.

Zolpidem Tartrate 5mg Tablets

Zolpidem tartrate 5mg immediate-release tablets for short-term insomnia treatment by enhancing GABA in CNS. Qualifies for HTS 3004.90.92.49 as other medicaments primarily affecting central nervous system, put up in measured doses for retail.